Cytosorb therapy

DEVICE2 trials

Sponsors

Ludwig-Maximilians - University of Munich, Sisli Hamidiye Etfal Training and Research Hospital

Conditions

Acute Kidney InjuryAcute Liver InjuryCytokine StormEndothelial DysfunctionRhabdomyolysis

Unknown Phase

Prospective Study for the Application of Cytosorb® in Critically Ill Patients

CompletedNCT04913298

Ludwig-Maximilians - University of MunichAcute Liver Injury, Cytokine Storm, Rhabdomyolysis

Start: 2021-03-01End: 2023-12-15Updated: 2024-02-22

Myoglobin Removal With CytoSorb in Rhabdomyolysis

CompletedNCT06503289

Sisli Hamidiye Etfal Training and Research HospitalAcute Kidney Injury, Endothelial Dysfunction, Rhabdomyolysis

Start: 2024-08-01End: 2025-05-01Updated: 2025-06-15

Related Papers

Correlation of bilirubin and toxic bile acids in critically ill patients with cholestatic liver dysfunction and adsorber application.

2024-09-182 citations

Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb® in Patients with Hyperinflammation: A Prospective Study

Infectious Diseases and Therapy2024-08-188 citations

Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb® in patients with severe rhabdomyolysis: a prospective trial.

2024-06-2212 citations

Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study.

2023-11-0916 citations